The polymerase chain reaction (PCR) represents an alternative to the current methods for investigating DNA damage and repair in specific genomic segments. In theory, any DNA lesion which blocks Taq polymerase can be measured by this assay. We used quantitative PCR (QPCR) to determine the lesion frequencies produced by cisplatin and ultraviolet light (UV) in a 2.3 kilobase (kb) segment of mitochondrial DNA and a 2.6 kb segment of the DHFR gene in mouse leukemia LI 210 cells. The frequency of UV-induced lesions increased linearly with dose, and was 0.58 lesions/10 kb/10 J/m2 in the mitochondrial DNA, and 0.37 lesions/10 kb/10 J/m2 in the DHFR gene. With cisplatin, the lesion frequency also increased linearly with dose, and was 0.17 lesions/10 kb/10 1M in the DHFR gene, and 0.07 lesions/i 0 kb/10 zM in mitochondrial DNA. This result is contrary to that of Murata et al., 1990 (1), in which mitochondrial DNA received greater cisplatin damage than did nuclear DNA. Using PCR to measure the repair of UV-induced lesions in the DHFR gene segment, we observed that less than 10% of the lesions were removed by 4 h, but over 70% of the lesions were removed by 8 h. Repair of 43% of UV-induced lesions in mitochondrial DNA was also observed during a 24 h period.
INTRODUCTION
There is now a large amount of evidence which indicates that the repair of specific DNA lesions does not occur equally throughout the entire genome, but varies in accordance with such factors as chromatin structure, sequence context and transcriptional activity (2) . For example, ultraviolet (UV)-induced pyrimidine dimers are removed from actively transcribed genes more efficiently than from nontranscribed regions of the genome (3) (4) (5) (6) (7) . This gene-specific repair is apparently due to the rapid repair of the transcribed strand of certain actively expressed genes (8) (9) (10) . In addition, there is evidence that photoproducts (11) , cisplatin-DNA adducts (12) , aflatoxin BI induced lesions (6) and lesions induced by a some alkylating agents (13, 14) are also removed in a gene-specific manner. Such observations may reflect the varying accessibility of different genomic regions to DNA damaging agents, the varying accessibility of these genomic regions to DNA repair proteins and/or the coupling of DNA repair with other cellular processes such as transcription (2, 15, 16) .
Preferential repair of DNA damage in actively transcribed genes was initially identified using a Southern hybridization based assay employing T4 endonuclease V, which specifically cleaves DNA at pyrimidine dimer sites (17) . While this methodology has proven useful in the identification and study of gene-specific repair, it also has certain limitations, including the requirements for relatively large amounts of DNA, for specific restriction sites flanking the region to be studied, and most importantly, for a lesion specific endonuclease to incise near the damaged nucleotide. Because of this latter requirement, most of the investigations using this assay have focused on the repair of UVinduced pyrimidine dimers, recognized by T4 endonuclease V. In order to use the Southern hybridization assay to investigate the repair of other lesions in specific genomic regions, some investigators (12, 13, 18) have used the Escherichia coli UvrABC nuclease complex (19) . However, this approach has certain limitations. Since the UvrABC complex only produces stoichiometric incisions, the use of this enzyme complex for single-copy genes is difficult (due to the large amount of DNA). Furthermore, for quantitative purposes, it is necessary to measure the UvrABC incision efficiency for each lesion studied.
A new approach to investigate DNA damage and repair in specific genomic regions using the polymerase chain reaction (PCR) has recently been reported (20) . This assay is based on the fact that many DNA lesions can block the Taq polymerase, and thereby result in a decrease in amplification of a damaged DNA segment compared to the amplification of the same segment in a nondamaged template. Poisson analysis is then used to determine the lesion frequency. A quantitative PCR assay thus has the potential to measure the lesion frequency and subsequent repair of any DNA damaging agent which blocks Taq polymerase (or other polymerases used in PCR) in any DNA segment for which flanking sequences are known. The initial investigation of Govan et al (20) , however, did not fully demonstrate the power of the assay because of the small size of the segments being amplified ( < 450 bp). This limited the sensitivity of the assay, and thus made necessary the use of extremely large doses of UV (1-24 UJ/m2) which greatly exceeded the range generally considered to be biologically relevant (17) . In (21) was amplified using the Mito 1 and Mito 2 primers, and a 2.6 kb segment of the DHFR gene (22) was amplified using the DHFR 1 and DHFR 2 primers (Figure 1) . In 23 ). The probe was prepared using a random-oligolabeling kit (Pharmacia, Piscataway, NJ) and purified by gel filtration using mini-spin columns (Worthington, Freehold, NJ). T4 Endonuclease V reactions. Endonuclease V from T4-phage was partially purified from the E. coli strain AB2480, which carried the over producing plasmid, pTac-denV (27) HC1 (pH 7.5), 10 (Figure 2A) , and for the multicopy mitochondrial DNA segment, using 500 ng of total genomic DNA, this was between 6 and 12 cycles ( Figure 2B Cisplatin Dose (AM) Figure 3 . Figure 3A ). With cisplatin, amplification decreased in a dose dependent manner from 0-150 itM in the DHFR gene ( Figure 3B ). The cisplatin-DNA lesion frequency increased linearly with dose, and when normalized, was 0.17 lesions/10 kb/10 ytM cisplatin ( Figure 3C ). In the mitochondrial DNA segment, however, cisplatin did not produce a significant decrease in amplification until over 100 AM ( Figure 3B ), and the lesion frequency when normalized, 0.066 lesions/O0 kb/10 itM cisplatin, was less than for the DHFR gene ( Figure 3C ). This result is contrary to an earlier finding in human malignant melanoma cells which showed mitochondrial DNA (when exposed to cisplatin) to receive more damage than nuclear DNA (1).
Validation of the QPCR gene-specific repair assay required that the sensitivity and detection limits match or exceed those observed with Southern hybridization based repair assays. We sought to directly compare both methods using the same damaged DNA. To this end, we have adapted the gene specific repair assay of Bohr and Hanawalt (3,4,11) for the quantification of DNA lesion frequencies in the mitochondrial genome. This approach uses total cellular DNA, making unnecessary the purification of mitochondrial DNA, and is dependent upon the quantitative conversion of DNA lesions into strand breaks by a damage specific endonuclease. Analysis of the DNA by electrophoresis on alkaline agarose gels, blotting to a nylon membrane and visualization by a radiolabeled mitochondrial probe allowed direct quantification of mitochondrial DNA lesions (see Materials and Methods). EcoRI digestion of the mouse mitochondrial genome results in three DNA fragments of 14.0 kb, 2.0 kb and 0.2 kb in length. All analyses were conducted on the 14.0 kb band.
To quantify the yield of cisplatin-DNA lesions, the UvrABC nuclease was used. This repair enzyme recognizes over 20 different types of DNA lesion (19) , and has recently been used to monitor the repair of N-acetoxyaminofluorene adducts and cisplatin-DNA adducts in the DHFR gene of CHO cells (12, 37 (38) and UV-induced photoproducts do block Taq polymerase (39) . In addition, we have confirmed this for UV-induced photoproducts by primer extension experiments using M13 RF and mitochondrial DNA templates (data not shown). Bohr et al, using the Southern based hybridization assay with T4 endonuclease V after UV irradiation, calculated a lesion frequency of 0.6 pyrimidine dimer sites/10 kb/10 J/m2 in the amplified DHFR gene of CHO cells, and 0.7 lesions/10 kb/10 J/m2 in the DNA overall (3). Madhani et al (4) , using the same assay in mouse fibroblasts, determined a lesion frequency of 0.47 lesions/10 kb/10 J/m2. Our QPCR calculated UV-induced lesion frequencies of 0.58 lesions/10 kb/10 J/m2 in mitochondrial DNA and 0.37/10 kb/10 J/m2 in the DHFR gene closely agree with these data. The slightly higher frequency (approximately 1.5 fold higher) of UV-induced lesions in mitochondrial DNA might reflect the higher AT content of mitochondrial DNA compared to chromosomal DNA, or differences in chromatin structure between the two locations which result in differences in shielding (40) demonstrates that the sensitivity of QPCR is at least 3 to 5 times greater to that with UvrABC and Southern analysis. Besides the nuclear DNA, another cellular target for DNA damaging agents is the mitochondrial genome. It has previously been reported that mitochondrial DNA sustains greater levels of damage than nuclear DNA when both are exposed to certain chemicals (41) (42) (43) (44) (45) (46) . Recently, in human malignant melanoma cells, higher levels of cisplatin-DNA adducts were observed in the mitochondrial DNA than in the chromosomal DNA (1). The results presented here show the opposite ( Figure 3C ). frequency is due to dilution from DNA replication. The initial low level of lesion removal during the first 4 h could be due to transient, enzymatically induced breaks which occur in DNA during repair. Such breaks would represent absolute blocks to Taq polymerase during PCR. Subsequent repair of these breaks could result in the observed period of faster repair between 4 and 8 h.
In the mitochondrial DNA, over 40% of the UV-induced lesions which block Taq polymerase were removed by 24 h after irradiation with 20 J/m2 (Figure 8 ). Although past investigations have shown that little or no excision repair occurs in mitochondrial DNA (49, 50) , recent evidence suggests that some types of lesions are repaired by other pathways (51, 52 
